(Q51816562)

13 April 2018

title

Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion. (English)

1 reference

13 April 2018

author name string

Jonathan Michaud-Levesque

series ordinal

1

1 reference

13 April 2018

Michel Demeule

series ordinal

2

1 reference

13 April 2018

Richard Béliveau

series ordinal

3

1 reference

13 April 2018

language of work or name

English

0 references

publication date

1 August 2005

1 reference

13 April 2018

Experimental Cell Research

published in

1 reference

13 April 2018

volume

308

1 reference

13 April 2018

issue

2

1 reference

13 April 2018

page(s)

479-490

1 reference

13 April 2018

Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Plasminogen binding and cancer: promises and pitfalls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Regulation of plasminogen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Role of plasminogen activator-plasmin system in tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The plasminogen activation system in tumor growth, invasion, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Human melanoma-associated antigen p97 is structurally and functionally related to transferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Human melanotransferrin (p97) has only one functional iron-binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Analysis of normal neoplastic human tissues for the tumor-associated protein p97

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

In situ localization of melanotransferrin (melanoma-associated antigen P97) in human liver. A light- and electronmicroscopic immunohistochemical study

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Expression of membrane-bound transferrin-like protein p97 on the cell surface of chondrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

A second melanotransferrin gene (MTf2) and a novel protein isoform: explanation for the membrane-bound and soluble forms of melanotransferrin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The membrane-bound transferrin homologue melanotransferrin: roles other than iron transport?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Deletion of the GPI pre-anchor sequence in human p97--a general approach for generating the soluble form of GPI-linked proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

A novel iron uptake mechanism mediated by GPI-anchored human p97

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The urokinase-type plasminogen activator system in cancer metastasis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The cell biology of the plasminogen system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.05.004

10.1016/J.YEXCR.2005.05.004

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018